Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank13
3Y CAGR+26.0%
5Y CAGR-19.2%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+26.0%/yr
vs -34.8%/yr prior
5Y CAGR
-19.2%/yr
Recent acceleration
Acceleration
+60.8pp
Accelerating
Percentile
P13
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $16000.00 | -5.9% |
| 2024 | $17000.00 | -26.1% |
| 2023 | $23000.00 | +187.5% |
| 2022 | $8000.00 | -65.2% |
| 2021 | $23000.00 | -50.6% |
| 2020 | $46600.00 | -11.7% |
| 2019 | $52789.00 | +19.4% |
| 2018 | $44197.00 | -65.7% |
| 2017 | $128994.00 | -57.5% |
| 2016 | $303482.00 | - |